These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17434211)

  • 1. Dichotomous effects of C-C chemokines in HIV-1 pathogenesis.
    Ansari AW; Heiken H; Moenkemeyer M; Schmidt RE
    Immunol Lett; 2007 May; 110(1):1-5. PubMed ID: 17434211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCL2: a potential prognostic marker and target of anti-inflammatory strategy in HIV/AIDS pathogenesis.
    Ansari AW; Heiken H; Meyer-Olson D; Schmidt RE
    Eur J Immunol; 2011 Dec; 41(12):3412-8. PubMed ID: 22076814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR4-tropic HIV-1 suppresses replication of CCR5-tropic HIV-1 in human lymphoid tissue by selective induction of CC-chemokines.
    Ito Y; Grivel JC; Chen S; Kiselyeva Y; Reichelderfer P; Margolis L
    J Infect Dis; 2004 Feb; 189(3):506-14. PubMed ID: 14745709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of chemokines in the HIV infection process].
    Proost P; Schols D
    Verh K Acad Geneeskd Belg; 2002; 64(6):403-20. PubMed ID: 12649932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocyte/macrophage-derived CC chemokines and their modulation by HIV-1 and cytokines: a complex network of interactions influencing viral replication and AIDS pathogenesis.
    Fantuzzi L; Belardelli F; Gessani S
    J Leukoc Biol; 2003 Nov; 74(5):719-25. PubMed ID: 12960239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5- and CXCR4-tropic HIV-1.
    Grivel JC; Elliott J; Lisco A; Biancotto A; Condack C; Shattock RJ; McGowan I; Margolis L; Anton P
    AIDS; 2007 Jun; 21(10):1263-72. PubMed ID: 17545702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine control of HIV-1 infection.
    Mellado M; Rodríguez-Frade JM; Vila-Coro AJ; de Ana AM; Martínez-A C
    Nature; 1999 Aug; 400(6746):723-4. PubMed ID: 10466720
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemokines and chemokine receptors in HIV infection: role in pathogenesis and therapeutics.
    Suresh P; Wanchu A
    J Postgrad Med; 2006; 52(3):210-7. PubMed ID: 16855325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of cytokines, chemokines and their receptors on HIV-1 replication in monocytes and macrophages.
    Kedzierska K; Crowe SM; Turville S; Cunningham AL
    Rev Med Virol; 2003; 13(1):39-56. PubMed ID: 12516061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemokine receptors: their role in human immunodeficiency virus (HIV) pathogenicity and resistance to HIV infections].
    Us D
    Mikrobiyol Bul; 2003 Jan; 37(1):75-87. PubMed ID: 12838682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dichotomous effects of beta-chemokines on HIV replication in monocytes and monocyte-derived macrophages.
    Kelly MD; Naif HM; Adams SL; Cunningham AL; Lloyd AR
    J Immunol; 1998 Apr; 160(7):3091-5. PubMed ID: 9531262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
    Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
    AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemokine receptors and its importance in the replication cycle of human immunodeficiency virus: clinical and therapeutic implications].
    Azevedo-Pereira JM; Santos-Costa Q
    Acta Med Port; 2008; 21(5):497-504. PubMed ID: 19187693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-chemokines and protection from HIV type 1 disease.
    Garzino-Demo A; DeVico AL; Cocchi F; Gallo RC
    AIDS Res Hum Retroviruses; 1998 Jun; 14 Suppl 2():S177-84. PubMed ID: 9672236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms.
    Dolan MJ; Kulkarni H; Camargo JF; He W; Smith A; Anaya JM; Miura T; Hecht FM; Mamtani M; Pereyra F; Marconi V; Mangano A; Sen L; Bologna R; Clark RA; Anderson SA; Delmar J; O'Connell RJ; Lloyd A; Martin J; Ahuja SS; Agan BK; Walker BD; Deeks SG; Ahuja SK
    Nat Immunol; 2007 Dec; 8(12):1324-36. PubMed ID: 17952079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians.
    Dubey S; Khalid M; Wesley C; Khan SA; Wanchu A; Jameel S
    J Clin Virol; 2008 Sep; 43(1):25-31. PubMed ID: 18462992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CC-chemokine receptor 5 (CCR5) in hepatitis C--at the crossroads of the antiviral immune response?
    Ahlenstiel G; Woitas RP; Rockstroh J; Spengler U
    J Antimicrob Chemother; 2004 Jun; 53(6):895-8. PubMed ID: 15128728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV/AIDS. HIV: experiencing the pressures of modern life.
    Nolan D; James I; Mallal S
    Science; 2005 Mar; 307(5714):1422-4. PubMed ID: 15746416
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemokine inhibitors for HIV.
    Eccleston A
    Nat Biotechnol; 1997 Aug; 15(8):709, 710. PubMed ID: 9255775
    [No Abstract]   [Full Text] [Related]  

  • 20. Tetrahydrocannabinol suppresses immune function and enhances HIV replication in the huPBL-SCID mouse.
    Roth MD; Tashkin DP; Whittaker KM; Choi R; Baldwin GC
    Life Sci; 2005 Aug; 77(14):1711-22. PubMed ID: 15964028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.